American Scandal: Encore: Theranos | The Race to Publish | 3
Host: Lindsay Graham
Author: Wondery
Release Date: October 1, 2024
Introduction to Theranos and Elizabeth Holmes
In the spring of 2015, Elizabeth Holmes stood at the pinnacle of Silicon Valley fame. Regarded as a visionary and a pioneering female entrepreneur, Holmes had successfully positioned Theranos as a revolutionary force in the healthcare industry. Recognized by Forbes as the youngest self-made female billionaire and invited by President Barack Obama to serve as a global ambassador for entrepreneurship, Holmes's public image was untarnished. However, beneath the surface, Theranos grappled with malfunctioning blood testing devices, setting the stage for a monumental scandal.
John Carreyrou's Investigation Begins
John Carreyrou, a respected reporter at the Wall Street Journal, found himself drawn into the Theranos controversy after completing an exhaustive investigative piece on Medicare fraud. Seeking his next big story, Carreyrou received a mysterious tip from Adam Clapper, a physician and blogger who had raised questions about Theranos's claims. As Carreyrou delved deeper, he sensed that Theranos's success was built on a foundation of deceit.
“Well, if this is for real and they want to talk, send them my way, please. Course. But there's one more thing. Please be delicate with this one.”—[02:30]
Interview with Alan Beam and Other Sources
Persisting in his investigation, Carreyrou connected with Alan Beam, a former Theranos lab director. Beam provided crucial insights into the company's operations, revealing that the proprietary Edison devices were unreliable. Instead of developing their own technology, Theranos had resorted to using third-party equipment, necessitating the dilution of blood samples—contradicting their promise of requiring only a single drop.
“The Edison devices didn't work, Theranos began to use other companies’ equipment. But that created a new problem.”—[12:45]
Beam further disclosed the internal pressure exerted by Sonny Balwani, Theranos's COO, who intimidated employees to suppress dissent. Carreyrou's notes swelled with damaging information, painting a harrowing picture of corporate malfeasance.
Impact of the Investigation and Public Response
As Carreyrou prepared to publish his findings, Elizabeth Holmes launched a strategic public relations campaign to counteract the emerging negative narrative. A pivotal moment occurred during a high-profile lab tour with Vice President Joe Biden, showcasing a fabricated state-of-the-art facility to solidify Theranos's credibility.
“Theranos is clearly the future of medicine.”—[28:15]
However, Carreyrou’s article, published in July 2015, exposed the discrepancies between Theranos's promises and its actual capabilities. The Wall Street Journal's coverage ignited widespread scrutiny, leading to legal threats and attempts by Theranos to destabilize the investigation by intimidating sources and mounting lawsuits.
Legal Challenges and Final Outcome
Despite Theranos's aggressive tactics, including attempts to influence Rupert Murdoch of News Corporation, the investigative efforts remained steadfast. Carreyrou and his editor, Mike Siconolfi, navigated internal pressures to expedite publication, adhering to journalistic integrity.
“We wait until all the pieces fall into place and Theranos has forgotten about us, and then we strike.”—[18:30]
The publication of the Wall Street Journal article marked the beginning of Theranos's rapid decline. Subsequent lawsuits from partners like Walgreens and charges from the Securities and Exchange Commission (SEC) for wire fraud against Holmes and Balwani culminated in Theranos dissolving in 2018. The criminal trial of Elizabeth Holmes commenced in September 2021, underscoring the severity of the fraud.
Key Insights and Conclusions
The Theranos scandal, as chronicled in this episode, underscores the perilous intersection of ambition, deception, and the quest for innovation. Elizabeth Holmes's rise and fall exemplify how unchecked ambition and a lack of transparency can lead to catastrophic consequences, not just for a company but for countless lives affected by fraudulent medical claims.
“For Elizabeth Holmes, this is a new beginning.”—[40:45]
The investigation highlights the critical role of diligent journalism in holding powerful entities accountable. John Carreyrou's relentless pursuit of the truth serves as a testament to the importance of integrity and courage in uncovering systemic fraud.
Notable Quotes
-
Alan Beam:
“The Edison devices didn't work, Theranos began to use other companies’ equipment. But that created a new problem.”—[12:45] -
Vice President Joe Biden:
“Theranos is clearly the future of medicine.”—[28:15] -
Editor Mike Siconolfi:
“La Matanza is how we win. We wait until all the pieces fall into place and Theranos has forgotten about us, and then we strike.”—[18:30] -
Elizabeth Holmes:
“Theranos isn't done. We won't be taken down by a desperate man looking for a good quote.”—[35:33]
Conclusion
Episode three of the Theranos series, "The Race to Publish," meticulously traces the unraveling of one of Silicon Valley's most audacious scandals. From Elizabeth Holmes's meteoric rise to the relentless investigative journalism that exposed her deception, the episode offers a comprehensive look into how ambition and deceit can overshadow innovation. As Carreyrou's story unfolds, listeners are left contemplating the broader implications of unchecked corporate power and the essential role of transparency in safeguarding public trust.
Next Episode Preview:
In the following episode, Lindsay Graham sits down with Charles Duhigg, bestselling author of The Power of Habit, to explore the tumultuous relationship between venture capitalists and tech companies, and whether powerful investors set the stage for fraud.
Credits:
American Scandal is produced, hosted, edited, and executive produced by Lindsay Graham for Wondery. Written by Samantha Charlotte, with editing by Christina Malzberger, senior production by Gabe Riven, and executive production by Stephanie Jenz, Jenny Lauer Beckman, and Hernan Lopez.
Recommended Reading:
For those interested in delving deeper into the Theranos scandal, it is highly recommended to read "Bad Blood: Secrets and Lies in a Silicon Valley Startup" by John Carreyrou.